Bioactive Compounds List
Type Distribution
Max Phase Distribution
Bioactive Compounds List
| Bio ID | Target ID | Target Name | ChEMBL ID | Name | Type | Max Phase | Molecular Weight | Targets | Bioactivities | Molecular Formula | Details |
|---|---|---|---|---|---|---|---|---|---|---|---|
| bio1881 | Tar11 | Proto-oncogene c-RAF (c-RAF) | CHEMBL2013119 | RIGOSERTIB SODIUM | Small molecule | Phase 3 | 473.48 | 53.0 | 108.0 | C21H24NNaO8S | Details |
| bio1882 | Tar11 | Proto-oncogene c-RAF (c-RAF) | CHEMBL4802222 | OSTABOLIN-C | Unknown | Phase 2 | -- | -- | -- | -- | Details |
| bio1883 | Tar11 | Proto-oncogene c-RAF (c-RAF) | CHEMBL1201577 | CETUXIMAB | Antibody | Phase 4 | -- | -- | -- | -- | Details |
| bio1884 | Tar11 | Proto-oncogene c-RAF (c-RAF) | CHEMBL1683 | HYDROCORTISONE BUTYRATE | Small molecule | Phase 4 | 432.56 | 72.0 | 91.0 | C25H36O6 | Details |
| bio1885 | Tar11 | Proto-oncogene c-RAF (c-RAF) | CHEMBL476413 | JHU-75528 C-11 | Small molecule | Early Phase 1 | 469.36 | 2.0 | 2.0 | C23H21Cl2N5O2 | Details |
| bio1886 | Tar11 | Proto-oncogene c-RAF (c-RAF) | CHEMBL1201012 | FLURANDRENOLIDE | Small molecule | Phase 4 | 436.52 | 135.0 | 346.0 | C24H33FO6 | Details |
| bio1887 | Tar11 | Proto-oncogene c-RAF (c-RAF) | CHEMBL1336 | SORAFENIB | Small molecule | Phase 4 | 464.83 | 1321.0 | 5601.0 | C21H16ClF3N4O3 | Details |
| bio1888 | Tar11 | Proto-oncogene c-RAF (c-RAF) | CHEMBL105 | MITOMYCIN | Small molecule | Phase 4 | 334.33 | 892.0 | 2502.0 | C15H18N4O5 | Details |
| bio1889 | Tar11 | Proto-oncogene c-RAF (c-RAF) | CHEMBL4297348 | BRIMAPITIDE, C-TERMINAL ACID | Protein | Phase 3 | 3823.50 | -- | -- | C164H285N65O41 | Details |
| bio1890 | Tar11 | Proto-oncogene c-RAF (c-RAF) | CHEMBL3977543 | BELVARAFENIB | Small molecule | Phase 2 | 478.94 | 5.0 | 6.0 | C23H16ClFN6OS | Details |